Helicore Biopharma

San Mateo, United States

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

$65.0M raised

Jan 2025

Series A

Biopharma Biotechnology Health Care Medical Therapeutics

Top Investors

Wellington ManagementOrbiMedVersant VenturesLongitude Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Helicore Biopharma

How much funding has Helicore Biopharma raised?

Helicore Biopharma has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.

Who are Helicore Biopharma's investors?

Helicore Biopharma's investors include Wellington Management, OrbiMed, Versant Ventures, Longitude Capital.

Where is Helicore Biopharma headquartered?

Helicore Biopharma is headquartered in San Mateo, United States.

What does Helicore Biopharma do?

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

What stage is Helicore Biopharma at?

Helicore Biopharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 28, 2025.

MLA

"Helicore Biopharma — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/helicore-biopharma. Accessed June 10, 2026.

APA

VCBacked. (2025). Helicore Biopharma — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/helicore-biopharma

Wikipedia (cite web)

{{cite web |title=Helicore Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/helicore-biopharma |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 28, 2025.

Similar Companies in Biopharma